Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aligos Therapeutics, Inc.

10.76
-0.9100-7.80%
Post-market: 10.760.00000.00%16:05 EDT
Volume:108.72K
Turnover:1.19M
Market Cap:65.79M
PE:-0.83
High:11.44
Open:11.04
Low:10.68
Close:11.67
Loading ...

BUZZ-Aligos Therapeutics rises after $105 million private placement

Reuters
·
12 Feb

Aligos Therapeutics Inc - Funding Expected to Extend Cash Runway Into Second Half of 2026

THOMSON REUTERS
·
12 Feb

Aligos Therapeutics Announces $105 Million Private Placement Financing

THOMSON REUTERS
·
12 Feb

Aligos Therapeutics Announces $105 Million Private Placement Financing

GlobeNewswire
·
12 Feb

Here's Why Aligos Therapeutics (NASDAQ:ALGS) Must Use Its Cash Wisely

Simply Wall St.
·
08 Feb

PTC Therapeutics (PTCT) Moves 9.0% Higher: Will This Strength Last?

Zacks
·
04 Feb

Aligos Therapeutics Appoints Lesley Ann Calhoun as COO

TIPRANKS
·
04 Feb

Here’s Why Aligos Therapeutics, Inc. (ALGS) Is Skyrocketing

Insider Monkey
·
14 Jan

Aligos Therapeutics, Inc.'s (NASDAQ:ALGS) biggest owners are retail investors who got richer after stock soared 17% last week

Simply Wall St.
·
21 Dec 2024

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
13 Dec 2024

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
13 Dec 2024

Aligos Therapeutics to Present at Investor Conferences in December

GlobeNewswire
·
26 Nov 2024

Aligos Therapeutics down 8% after data presented at The Liver Meeting

TIPRANKS
·
20 Nov 2024

Aligos Therapeutics trading resumes

TIPRANKS
·
20 Nov 2024

Aligos Therapeutics Presents Positive Data at The Liver Meeting (TLM) 2024

GlobeNewswire
·
20 Nov 2024

Bylvay® (odevixibat) data shows sustained improvement in severe itch and serum bile acid levels in patients with PFIC and ALGS

GlobeNewswire
·
18 Nov 2024